Wednesday, May 20, 2009

NIH Treads Where Drug Industry Rarely Goes

It's trying to do preliminary research that makes it less risky for drug makers to run trials of experimental drugs for rare diseases.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)